Medicine & Life Sciences
Drug Discovery
100%
Structure-Activity Relationship
64%
Cyclic GMP-Dependent Protein Kinases
53%
Phosphodiesterase 5 Inhibitors
52%
epigallocatechin gallate
51%
Diamines
47%
Organic Chemistry
47%
Pharmaceutical Chemistry
47%
Serotonin Uptake Inhibitors
44%
Plasmodium falciparum
42%
staurosporine aglycone
40%
Brugia malayi
38%
Phosphoric Diester Hydrolases
36%
Pharmaceutical Preparations
35%
7-(4-(3-(1H-inden-3-yl)propyl)piperazin-1-yl)-1,3-benzoxazol-2(3H)-one
34%
Sildenafil Citrate
33%
Erectile Dysfunction
33%
Phosphodiesterase Inhibitors
32%
SB-480848
31%
Cyclohexenes
30%
Epoxy Compounds
29%
Hydroxyl Radical
29%
ophiobolins
29%
tropone
28%
Carbamates
28%
ophiobolin A
27%
Enzymes
27%
Schizophrenia
27%
Calcium-Sensing Receptors
26%
N-(2-hydroxy-3-(2-cyano-3-chlorophenoxy)propyl)-1,1-dimethyl-2-(2-nephthyl)ethylamine
25%
Hydroxyquinolines
25%
Amides
24%
Dopamine D2 Receptors
23%
In Vitro Techniques
23%
Enzyme Inhibitors
23%
Dopamine
22%
Choline O-Acetyltransferase
22%
Psychological Inhibition
22%
carbazole
21%
N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide
21%
Wuchereria bancrofti
20%
Ligands
20%
Sulfonamides
20%
Histone Demethylases
19%
Esters
19%
Therapeutics
19%
Ketones
19%
HSP90 Heat-Shock Proteins
19%
Filarial Elephantiasis
18%
Cyclic AMP-Dependent Protein Kinases
18%
Chemical Compounds
Phosphodiesterase V Inhibitor
63%
Structure-Activity Relationship
54%
(-)-Epigallocatechin
52%
Sildenafil
47%
Agent Interacting With Transmitter, Hormone or Drug Receptor
45%
Neurotrophic
43%
Hsp90 Inhibitor
43%
Protein
40%
Parasitic
37%
Gallate
36%
Erythro Isomer
36%
Drug
35%
Partial Agonist
34%
Photocyclization
34%
Diastereomer
31%
Diamine
30%
Serotonin
29%
Chemistry
29%
Ophiobolin A
27%
K-252a
26%
Boceprevir
26%
Stereochemistry
25%
Dopamine
25%
Iodolactonization
25%
Antitumor
24%
Threo Isomer
24%
Disorder
23%
Hydroxyl
22%
Ester
22%
Cord
22%
Vinyllithium
22%
Choline
21%
Molecule
21%
Dipeptidyl Peptidase IV Inhibitor
21%
Dose
20%
EC 3.1.4.* (Phosphoric Diester Hydrolase) Inhibitor
20%
Protein Kinase Inhibitor
20%
Oxirane
19%
Tertiary Amide
18%
Application
17%
Epoxide
17%
Baeyer-Villiger Oxidation
17%
Amino Acid Ester
17%
Dihydrofolates
17%
Ethylamine
16%
Sulfonamide
16%
Neurotoxin
16%
Cyclohexene
15%
Enzyme Inhibitor
15%
Borohydride
15%